Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated Fli-1-haploinsufficient mice. [electronic resource]
Producer: 20150421Description: 517-26 p. digitalISSN:- 2326-5205
- Animals
- Bleomycin -- adverse effects
- Cell Movement -- physiology
- Cytokines -- metabolism
- Disease Models, Animal
- Endothelium, Vascular -- pathology
- Epithelial-Mesenchymal Transition -- physiology
- Female
- Fibrosis
- Haploinsufficiency -- genetics
- Immune System -- pathology
- Integrins -- metabolism
- Macrophages -- pathology
- Mast Cells -- pathology
- Mice
- Mice, Inbred C57BL
- Mice, Mutant Strains
- Proto-Oncogene Protein c-fli-1 -- deficiency
- Scleroderma, Systemic -- chemically induced
- Skin -- metabolism
- Transforming Growth Factor beta -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.